These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 24632553)
1. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma. Ben Q; Zheng J; Fei J; An W; Li P; Li Z; Yuan Y Pancreas; 2014 Jul; 43(5):744-9. PubMed ID: 24632553 [TBL] [Abstract][Full Text] [Related]
2. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer. Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553 [TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Parikh AA; Liu WB; Fan F; Stoeltzing O; Reinmuth N; Bruns CJ; Bucana CD; Evans DB; Ellis LM Cancer; 2003 Aug; 98(4):720-9. PubMed ID: 12910515 [TBL] [Abstract][Full Text] [Related]
5. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma. Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054 [TBL] [Abstract][Full Text] [Related]
6. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Dallas NA; Gray MJ; Xia L; Fan F; van Buren G; Gaur P; Samuel S; Lim SJ; Arumugam T; Ramachandran V; Wang H; Ellis LM Clin Cancer Res; 2008 Dec; 14(24):8052-60. PubMed ID: 19088020 [TBL] [Abstract][Full Text] [Related]
7. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma. An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471 [TBL] [Abstract][Full Text] [Related]
8. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630 [TBL] [Abstract][Full Text] [Related]
10. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival. Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915 [TBL] [Abstract][Full Text] [Related]
13. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308 [TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma]. Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220 [TBL] [Abstract][Full Text] [Related]
15. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome. Kim JC; Kim KT; Park JT; Kim HJ; Sato Y; Kim HS Hepatogastroenterology; 2015; 62(138):251-6. PubMed ID: 25916042 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma. Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402 [TBL] [Abstract][Full Text] [Related]
17. Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Fermér C; Nilsson O; Seppänen H; Haglund C PLoS One; 2015; 10(6):e0129012. PubMed ID: 26053486 [TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Sun HC; Qiu ZJ; Liu J; Sun J; Jiang T; Huang KJ; Yao M; Huang C Int J Oncol; 2007 Jun; 30(6):1359-67. PubMed ID: 17487356 [TBL] [Abstract][Full Text] [Related]
19. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. Zhu Z; Xu Y; Du J; Tan J; Jiao H J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773 [TBL] [Abstract][Full Text] [Related]
20. The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas. Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y Dis Markers; 2015; 2015():379568. PubMed ID: 26294807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]